Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil-mediated promotion of DNA damage-driven cell death
Elvira Mukinovic, Sina Federmann, Larissa Messling, Marlena Sekeres, Julia Mann, Lena Abbey, Matthias Ulrich Kassack, Gerhard Fritz
This study identifies verapamil as a synergistic agent to overcome doxorubicin resistance in ovarian cancer cells by enhancing DNA damage and apoptosis.
bioRxiv · Apr 23, 2025 · PreprintPharmacology & Toxicology